Back
Nuveen S&P 500 Dynamic Overwrite Fund Vs. Neurogene Industry Stock Comparison
Sell
50
SPXX
Nuveen S&P 500 Dynamic Overwrite Fund
Last Price:
16.76
Seasonality Move:
1.84%
Buy
75
NGNE
Neurogene
Last Price:
64.32
Seasonality Move:
58.98%
Sell
50
Nuveen S&P 500 Dynamic Overwrite Fund (SPXX)
is a Sell
Is Nuveen S&P 500 Dynamic Overwrite Fund a Buy, Sell or Hold?
- The current Nuveen S&P 500 Dynamic Overwrite Fund [SPXX] share price is $16.61. The Score for SPXX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- SPXX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Neurogene (NGNE)
is a Buy
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SPXX Stock Price Chart
What is Nuveen S&P 500 Dynamic Overwrite Fund's stock price today?
-
The Nuveen S&P 500 Dynamic Overwrite Fund share price today is $16.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPXX is experiencing selling pressure, which indicates risk of future bearish movement.
NGNE Stock Price Chart
SPXX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 42.56 | Sell |
Chaikin Money Flow: | -16354 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.64 - 16.88) | Sell |
Bollinger Bands (100): | (16.12 - 16.76) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.06 | Buy |
Relative Strength Index (14 RSI): | 75.97 | Buy |
Chaikin Money Flow: | 176225 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.28 - 53.36) | Buy |
Bollinger Bands (100): | (34.64 - 46.72) | Buy |
SPXX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.78 | Sell |
20-day SMA: | 16.8 | Sell |
50-day SMA: | 16.65 | Sell |
200-day SMA: | 15.97 | Buy |
8-day EMA: | 16.74 | Sell |
20-day EMA: | 16.76 | Sell |
50-day EMA: | 16.63 | Sell |
200-day EMA: | 16.09 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.43 | Buy |
20-day SMA: | 49.56 | Buy |
50-day SMA: | 43.32 | Buy |
200-day SMA: | 37.93 | Buy |
8-day EMA: | 50.65 | Buy |
20-day EMA: | 48.54 | Buy |
50-day EMA: | 44.96 | Buy |
200-day EMA: | 36.96 | Buy |
Nuveen S&P 500 Dynamic Overwrite Fund Earnings Growth & SPXX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
Nuveen S&P 500 Dynamic Overwrite Fund Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |